<img alt="" height="1" width="1" />Ironwood, Almirall bowel drug meets main goalReutersO) said their experimental drug to treat irritable bowel syndrome (IBS) with constipation met the main goal of a late-stage European trial. ...Ironwood Pharmaceuticals irritable bowel syndrome drug meets late-stage study ...<nobr>CanadianBusiness.com</nobr>Ironwood Pharmaceuticals Announces Conference Call to Discuss Positive ...<nobr>MarketWatch (press release)</nobr>Ironwood Announces Positive Phase 3 Results, Shares Jump<nobr>Wall Street Journal</nobr><nobr>RTT News</nobr> -<nobr>StreetInsider.com (subscription)</nobr> -<nobr>Xconomy</nobr><nobr>all 49 news articles »</nobr> |